the savvy bacterium listeria monocytogenes uses a one-two punch to invade the intestinal epithelium,...

Upload: mickey-pentecost

Post on 03-Jun-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 The savvy bacterium Listeria monocytogenes uses a one-two punch to invade the intestinal epithelium, report Mic

    1/2

    R E S E A R C H H I G H L I G H T S

    AGING

    Blame it on acetylationDuring aging, the brain gene expression pro-

    gram changes, and people often suffer declines

    in learning and memory. A study in mice sug-

    gests that altered patterns of histone acetyla-

    tion may underlie this age-related decline.

    Previous studies have shown that chromatin

    plasticity and histone modifications, especially

    acetylation, are involved in long-term memory

    and regulation of gene expression. Shahaf

    Peleg et al. (Science328, 753756) exam-

    ined these processes in mice as they aged

    and found impaired acetylation of histone

    H4 Lys12 (H4K12).

    The researchers assessed the entire hip-

    pocampal transcriptome of aged mice right after

    subjecting them to fear conditioning training

    a test for learning and memory. Compared to

    younger mice, these animals failed to upregulategenes encoding proteins linked to learning and

    memory formation, such as formin-2an actin

    nucleator expressed in the brain. The research-

    ers traced the failure to upregulate these genes

    to defects in H4K12 acetylation, which specifi-

    cally affected transcriptional elongation.

    Treatment with a histone deacetylase

    inhibitor rescued the acetylation of H4K12

    in coding regions of learning-regulated genes

    in aged mice. The genes were upregulated

    and memory function reinstated during the

    learning test. CP

    REPRODUCTION

    Steroids fry brain, fry testesA new study in mice might give pause to

    adolescent boys contemplating using ste-

    roids. Synthetic derivatives of testosterone

    can alter a hormone-controlling circuit in the

    brain, leading to shrunken testes, accord-

    ing to a study in adolescent male mice

    (J. Neurosci.30, 64976506).

    Carlos Penatti et al. treated mice with

    17-methyltestosterone and looked at the

    response of neurons in the hypothalamusthat release gonadotropin-releasing hormone

    (GnRH). GnRH prompts the production of

    hormones that regulate key reproductive pro-

    cesses, such as spermatogenesis.

    The steroid-treated mice had reduced

    action potentials in GnRH neurons, reduced

    levels of reproductive hormones and reduced

    testes mass. The steroid does not seem to

    affect GnRH neurons directlyinstead, it

    affects a nearby part of the brain, the medial

    preoptic area (mPOA). Steroid administration

    increased the action potential frequency of

    neurons in the mPOA, which, in turn, damp-

    ened the firing rate of GnRH neurons.

    The findings jibe with observations that ste-

    roids can delay the onset of puberty in mice

    and can affect libido, testes health and sperm

    production in people. CS

    NEUROSCIENCE

    Trimming synapsesThe neurons of individuals with fragile X syn-

    drome contain an overabundance of synapses.

    A study in mice suggests that a failure in syn-

    aptic pruning may underlie this problem of

    excess (Neuron 66, 191197).

    The transcription factor myocyte enhancer

    factor-2 (MEF2) drives synaptic elimination in

    response to neuron firing. When Brad Pfeiffer

    et al. expressed a constitutively active form of

    MEF2 in hippocampal slice cultures from nor-

    mal mice, they observed a decrease in spine

    number and synaptic activity. These changes

    were not observed when MEF2 was expressedin slice cultures from mice deficient in FMRP,

    the protein behind fragile X syndrome. The

    researchers found that re-expressing FMRP at

    the synapses of these neurons could drive syn-

    aptic elimination in response to MEF2.

    FMRP and MEF2 did not seem to bind

    each other to exert their effects. Instead, the

    researchers suggest that these two factors may

    operate in a common pathwaywith MEF2

    inducing transcription in the nucleus and FMRP

    binding these transcripts once they arrive at

    the synapseto regulate synaptic elimination.

    Future work looking at the downstream targets

    of these factors could provide further insight

    into fragile X syndrome. EC

    IMMUNITY

    Balance in the bowelOne approach to treating inflammatory bowel

    disease, now in clinical trials, is to block the

    activity of OX40a molecule that ramps up

    the immune response by acting as a co-stim-

    ulatory receptor on T cells. New findings in

    mice sound a note of caution for this approach.

    It seems that blocking OX40 interferes with

    the function of regulatory T cells, cells that

    suppress activation of the immune system

    and dampen inflammation (J. Exp. Med. 207,

    699709).

    Colitis results from an imbalance between

    effector and regulatory T cells (Treg cells) in

    the gut. In mice, blocking OX40 can help rein

    in effector T cells and has shown therapeutic

    effects in animal models of colitis. To furtherexplore how OX40 affects the balance between

    immune cells, Thibault Griseri et al.turned

    to mice unable to form T and B cells (RAG-

    deficient mice). They transferred colitis-induc-

    ing T cells into these mice along with Treg cells.

    Concurrently transferring OX40-expressing

    Treg cells prevented development of disease,

    whereas transfer of Tregcells deficient in OX40

    resulted in severe inflammation and colitis.

    Unlike OX40-expressing Treg cells, OX40-

    deficient Tregcells failed to accumulate in the

    colon or lymphoid organs of RAG-deficient

    MICROBIOLOGY

    Leaping Listeria

    The savvy bacterium Listeria monocytogenesuses a

    one-two punch to invade the intestinal epithelium,

    report Mickey Pentecost etal.(PLoSPathog. 6,

    e1000900).

    At the tips of intestinal villi, extrusion ofdead cells causes the surrounding live cells to

    form multicellular junctions, where normally

    basolateral proteins, such as E-cadherin, are

    transiently exposed to the lumen.

    L. monocytogenescapitalizes on this quirk and

    uses the invasin protein InlA to bind E-cadherin

    and enter the cell.

    In their new study, Pentecost etal.find that L. monocytogenesdeploys a second invasin,

    InlB, to trigger signaling through another basolateral protein, c-Met. This signaling induces

    endocytosis of E-cadherin, accelerating L. monocytogenesinvasion at the multicellular

    junction. The researchers propose that other gastrointestinal pathogens may also take

    advantage of this unique entry site.

    In a separate study on L. monocytogenes, David Ribet et al.find that the microbe impairs

    an essential post-translational modification, SUMOylation (Nature464, 11921195).

    Theresearchers identified a specific bacterial protein that prompts the degradation of an enzyme

    in the SUMOylation machinery, thereby weakening the host immune response.KG

    L. monocytogenes(green) after invading an

    intestinal villus tip (red).

    P L o S P a t h o g e n s

    65 0

    VOLUME 16 |NUMBER 6 |JUNE 2010 NATURE MEDICINE

    2010N

    atureAmerica,

    Inc.

    Allrightsres

    erved.

  • 8/11/2019 The savvy bacterium Listeria monocytogenes uses a one-two punch to invade the intestinal epithelium, report Mic

    2/2

    R E S E A R C H H I G H L I G H T S

    mice during the early stages of disease. The

    researchers traced this defect to increased

    apoptosis and reduced activation of OX40-

    expressing Treg cells. They conclude that OX40

    may act as a survival signal in Treg cells. CP

    ATHEROSCLEROSIS

    Insulin controls adhesionInsulin signaling in the vasculature shields

    mice from atherosclerosis, according to new

    research (Cell Metab. 11, 379389).

    Studies on whether insulin prevents or

    promotes atherosclerosis are contradictory.

    To shed light on the conflict, Christian Rask-

    Madsen et al.deleted the gene encoding

    the insulin receptor in endothelial cells in

    apolipoprotein E (apoE)-deficient mice, a model

    of atherosclerosis. The double-knockout mice

    had larger and more complex aortic atheroscle-

    rotic lesions than did apoE-deficient mice.The researchers next examined recruit-

    ment and accumulation of

    inflammatory cells in the

    vasculature, a key step in

    the development of athero-

    sclerosis. They found that

    insulin seems to downregu-

    late VCAM-1, a molecule on

    the endothelium that binds

    leukocytes. Endothelial

    cells from the double-

    knockout mice, for instance,

    showed high expression of

    VCAM-1, compared to cells

    from apoE-deficient mice.

    Treating wild-type endothe-

    lial cells with insulin quashed

    VCAM-1 protein expression.

    In a system already prone to atherosclero-

    sis, it seems that insulin signaling can inhibit

    lesion formation by downregulating VCAM-1

    expression and leukocyte adhesion. The find-

    ings provide insight into how impaired insulin

    signaling in the endothelium in conditions

    such as type 2 diabetes should be managed to

    decrease the risk of atherosclerosis. AK

    Cholesterol microcontrolTwo new studies identify a noncoding RNA as a

    key regulator of cholesterol homeostasis.

    S. Hani Najafi-Shoushtari et al.found a

    conserved microRNA, miR-33, in the intronic

    sequences of two genes that encode sterol-

    regulatory element-binding protein (SREBP)

    transcription factors, proteins which promote

    the synthesis and uptake of cholesterol and lip-

    ids (Sciencedoi:10.1126/science.1189123).

    Katey Rayner et al.pulled the same miRNA out

    of a screen for miRNAs that respond to changes

    in cholesterol levels (Sciencedoi:10.1126/

    science.1189862).

    Expression of miR-33 mirrored that of its

    host SREBP genes in both mouse and human

    cells and tissues. Among other targets, miR-33

    quashes expression of ATP-binding cassette

    A1 (ABCA1)a transporter protein that medi-

    ates the formation of high-density lipoprotein

    (HDL), the 'good' cholesterol, and aids its efflux

    from cells. Overexpression of miR-33 in mice

    decreased ABCA1 protein expression, whereas

    inhibition of miR-33 increased ABCA1 expres-

    sion and raised circulating HDL levels.

    The findings suggest that manipulation of

    miR-33 expression has the therapeutic poten-

    tial to increase expression of ABCA1 and

    thereby raise HDL levels. AK

    GENOMICS

    The whole thing, lots of itA clinical annotation of the complete genome

    sequence of a healthy person has revealed dis-

    ease risks and drug response predictions (Lancet

    375, 15251535, 2010). But the work under-

    scores the bioinformatic challenges remaining

    before scientists can confidently apply genetic

    information to personalized medicine.

    Euan Ashley et al. scoured the DNA of a

    40-year-old man for 2.6 million single nucle-

    otide polymorphisms and more than 750 copy

    number variants. Incorporating family history,

    clinical measurements and known disease

    associations, they showed that this individual

    was at an elevated risk of developing sudden

    cardiac arrest, diabetes and some cancersand

    that he might benefit from cholesterol-lowering

    statins.

    The study emerges on the heels of two oth-

    ers comparing whole-genome sequences from

    people with rare genetic disorders to genetic

    information from unaffected relatives. Jared

    Roach et al. sequenced the DNA of a family

    of four, including two adult children who suf-

    fer from Miller's syndrome and primary cili-

    ary dyskinesia, and pinpointed the four genes

    responsible for the two diseases (Science328,636639, 2010).

    James Lupski, who is afflicted with a reces-

    sive form of Charcot-Marie-Tooth disease, ana-

    lyzed his own genome. He and his colleagues

    homed in on the mutation causing the condition

    in the Baylor College of Medicine geneticist and

    some of his family members (New Engl. J. Med.

    362, 11811191, 2010). ED

    New from NPG

    Mutations of optineurin in amyotrophic

    lateral sclerosis.

    Maruyama, H. et al. Nature465, 223226.

    A gene previously implicated in a form of

    glaucoma is now pinned to amyotrophiclateral sclerosis. Mutations in the

    gene affect signaling through NF-B,

    suggesting that NF-B inhibitors might

    be useful to treat the disease.

    Human T cell epitopes of

    Mycobacterium tuberculosis areevolutionarily hyperconserved.

    Comas, I. et al. Nat. Genet.published online,

    doi:10.1038/ng.590 (23 May).

    The bits of the M. tuberculosis

    bacterium recognized by the human

    immune system are highly conserved

    across strains. The findings suggest that

    the microbe might co-opt the immune

    response for its own ends and have

    implications for vaccine design.

    Bcl-2 and accelerated DNA repair

    mediates resistance of hair follicle

    bulge stem cells to DNA damage

    induced cell death.

    Sotiropoulou, P. A. et al. Nat. Cell Biol.published online, doi:10.1038/ncb2059

    (16 May).

    Stem cells in the skin are resistant to

    death in response to DNA damage,

    and they repair DNA relatively quickly.

    This speed is due to high activity of

    nonhomologous end joining, a repair

    mechanism that is prone to errors. It

    seems that these stem cells are primed

    to survive despite damage and tend to

    accumulate mutationsa finding with

    implications for tumorigenesis and aging.

    Chemical genetics strategy identifies

    an HCV NS5A inhibitor with a potent

    clinical effect.

    Gao, M. et al.Nature 465, 96100.

    In phase 1 clinical trials, a new drug

    substantially reduced the viral load of

    chronically infected subjects.

    Written by Eva Chmielnicki, Elie Dolgin,

    Katherine Gora, Anna Kushnir, Carolina Pola and

    Charlotte Schubert

    Plaques in

    the double

    knockout mice.

    NLRP3 inflammasomes are required

    for atherogenesis and activated by

    cholesterol crystals.

    Duewell, P. et al.Nature464, 13571361.

    The findings provide insight into the long-

    standing question of whether cholesterol

    is an early trigger of atherosclerosis

    or a consequence of the condition.

    Cholesterol crystals can activate a protein

    complex dubbed the inflammasome,

    resulting in inflammation that promotes

    atherosclerosis.

    CellPress

    NATURE MEDICINE

    VOLUME 16 |NUMBER 6 |JUNE 2010

    65 1

    2010N

    atureAmerica,

    Inc.

    Allrightsres

    erved.